Remnant cholesterol combined with LDL-C and risk of major adverse cardiovascular events in elderly hypertensive Patients: A retrospective cohort study

Residual cardiovascular risk remains in elderly hypertensive patients with LDL-C controlled LDL-C. Remnant cholesterol (RC) is associated with atherosclerotic cardiovascular disease, but evidence for the combined prognostic value of LDL-C and RC in elderly hypertensive patients is limited. This retrospective cohort study initially enrolled 871 elderly hypertensive patients admitted between January 2020 and December 2022 from Wuyi County Traditional Chinese Medicine Hospital; 847 patients completed follow-up and were included in outcome analysis, while 24 patients were lost to follow-up throughout the observational period. Patients were divided into four groups by baseline LDL-C (< 2.6 vs. ≥ 2.6 mmol/L) and RC (< 0.62 vs. ≥ 0.62 mmol/L). The primary endpoint was major adverse cardiovascular events (MACE). Multivariate Cox regression, Kaplan–Meier and subgroup analyses were performed. During a median 36-month follow-up, 23.3% (197/847) patients had MACE. The incidence increased stepwise: 14.4% (low LDL-C + low RC), 20.3% (high LDL-C + low RC), 25.6% (low LDL-C+high RC), 33.6% (high LDL-C+high RC) ( P < 0.001). In multivariate Cox regression analysis, baseline remnant cholesterol (RC) was associated with MACE (HR = 1.451, 95%CI 1.071–1.967, P = 0.016), whereas baseline LDL-C showed only a marginal association without statistical significance (HR = 1.197, 95%CI 0.983–1.459, P = 0.074). Elevated BNP also predicted MACE (HR = 1.004, 95%CI 1.001–1.008, P = 0.021). Compared with low LDL-C + low RC group, adjusted HRs were 1.401 ( P = 0.021), 1.755 ( P = 0.003) and 2.248 ( P = 0.002) in the other three groups respectively. Stratification based on LDL-C and RC levels identifies subgroups with distinct MACE risk among elderly hypertensive patients; patients with concurrent elevation of both lipids exhibited the highest cardiovascular event risk. Combined assessment of LDL-C and remnant cholesterol may help identify patients at higher MACE risk among elderly hypertensive individuals.

Authors

Publication Details

Journal
BMC Geriatrics
Published
2026-11-14
DOI
https://doi.org/10.1186/s12877-026-08706-x
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Remnant cholesterol combined with LDL-C and risk of major adverse cardiovascular events in elderly hypertensive Patients: A retrospective cohort study

Pei Wang, Yujing Zheng, Fang Chen
BMC Geriatrics
Lipoproteins and Cardiovascular Health
article

Remnant cholesterol combined with LDL-C and risk of major adverse cardiovascular events in elderly hypertensive Patients: A retrospective cohort study

Pei Wang, Yujing Zheng, Fang Chen
article en

Abstract

Residual cardiovascular risk remains in elderly hypertensive patients with LDL-C controlled LDL-C. Remnant cholesterol (RC) is associated with atherosclerotic cardiovascular disease, but evidence for the combined prognostic value of LDL-C and RC in elderly hypertensive patients is limited. This retrospective cohort study initially enrolled 871 elderly hypertensive patients admitted between January 2020 and December 2022 from Wuyi County Traditional Chinese Medicine Hospital; 847 patients completed follow-up and were included in outcome analysis, while 24 patients were lost to follow-up throughout the observational period. Patients were divided into four groups by baseline LDL-C (< 2.6 vs. ≥ 2.6 mmol/L) and RC (< 0.62 vs. ≥ 0.62 mmol/L). The primary endpoint was major adverse cardiovascular events (MACE). Multivariate Cox regression, Kaplan–Meier and subgroup analyses were performed. During a median 36-month follow-up, 23.3% (197/847) patients had MACE. The incidence increased stepwise: 14.4% (low LDL-C + low RC), 20.3% (high LDL-C + low RC), 25.6% (low LDL-C+high RC), 33.6% (high LDL-C+high RC) ( P < 0.001). In multivariate Cox regression analysis, baseline remnant cholesterol (RC) was associated with MACE (HR = 1.451, 95%CI 1.071–1.967, P = 0.016), whereas baseline LDL-C showed only a marginal association without statistical significance (HR = 1.197, 95%CI 0.983–1.459, P = 0.074). Elevated BNP also predicted MACE (HR = 1.004, 95%CI 1.001–1.008, P = 0.021). Compared with low LDL-C + low RC group, adjusted HRs were 1.401 ( P = 0.021), 1.755 ( P = 0.003) and 2.248 ( P = 0.002) in the other three groups respectively. Stratification based on LDL-C and RC levels identifies subgroups with distinct MACE risk among elderly hypertensive patients; patients with concurrent elevation of both lipids exhibited the highest cardiovascular event risk. Combined assessment of LDL-C and remnant cholesterol may help identify patients at higher MACE risk among elderly hypertensive individuals.

BMC Geriatrics
Lipoproteins and Cardiovascular Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon